These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 10568859
1. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats. Walker J, Catheline G, Guilbaud G, Kayser V. Pain; 1999 Dec; 83(3):509-516. PubMed ID: 10568859 [Abstract] [Full Text] [Related]
2. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis. Binder W, Walker JS. Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855 [Abstract] [Full Text] [Related]
3. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Jolivalt CG, Jiang Y, Freshwater JD, Bartoszyk GD, Calcutt NA. Diabetologia; 2006 Nov; 49(11):2775-85. PubMed ID: 16924480 [Abstract] [Full Text] [Related]
4. The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats. Catheline G, Kayser V, Idänpään-Heikkilä JJ, Guilbaud G. Eur J Pharmacol; 1996 Dec 30; 318(2-3):273-81. PubMed ID: 9016915 [Abstract] [Full Text] [Related]
5. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats. Catheline G, Guilbaud G, Kayser V. Eur J Pharmacol; 1998 Sep 18; 357(2-3):171-8. PubMed ID: 9797033 [Abstract] [Full Text] [Related]
6. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck KO, Murray RD, Simon M. Br J Pharmacol; 1994 Dec 18; 113(4):1317-27. PubMed ID: 7889287 [Abstract] [Full Text] [Related]
7. Effects of kappa opioids in the inflamed rat colon. Sengupta JN, Snider A, Su X, Gebhart GF. Pain; 1999 Feb 18; 79(2-3):175-85. PubMed ID: 10068163 [Abstract] [Full Text] [Related]
8. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats. Martinez V, Christensen D, Kayser V. Pain; 2002 Oct 18; 99(3):537-545. PubMed ID: 12406530 [Abstract] [Full Text] [Related]
9. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. Machelska H, Pflüger M, Weber W, Piranvisseh-Völk M, Daubert JD, Dehaven R, Stein C. J Pharmacol Exp Ther; 1999 Jul 18; 290(1):354-61. PubMed ID: 10381799 [Abstract] [Full Text] [Related]
10. Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats. Wala EP, Sloan PA, Holtman JR. J Opioid Manag; 2011 Jul 18; 7(5):377-89. PubMed ID: 22165037 [Abstract] [Full Text] [Related]
11. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain. Erichsen HK, Hao JX, Xu XJ, Blackburn-Munro G. Pain; 2005 Aug 18; 116(3):347-358. PubMed ID: 15982817 [Abstract] [Full Text] [Related]
12. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice. Sounvoravong S, Takahashi M, Nakashima MN, Nakashima K. J Pharmacol Sci; 2004 Mar 18; 94(3):305-12. PubMed ID: 15037816 [Abstract] [Full Text] [Related]
13. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats. He SQ, Yang F, Perez FM, Xu Q, Shechter R, Cheong YK, Carteret AF, Dong X, Sweitzer SM, Raja SN, Guan Y. Pain; 2013 Nov 18; 154(11):2477-2486. PubMed ID: 23880055 [Abstract] [Full Text] [Related]
14. Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the rat. Walker JS, Scott C, Bush KA, Kirkham BW. Neuropeptides; 2000 Nov 18; 34(3-4):193-202. PubMed ID: 11021980 [Abstract] [Full Text] [Related]
15. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat. Laurido C, Hernandez A, Perez H. Int J Neurosci; 1996 Nov 18; 87(3-4):191-9. PubMed ID: 9003979 [Abstract] [Full Text] [Related]
16. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model. Zhao M, Wang JY, Jia H, Tang JS. Brain Res; 2006 Mar 03; 1076(1):68-77. PubMed ID: 16476416 [Abstract] [Full Text] [Related]
17. Ultralow dose fentanyl prevents development of chronic neuropathic pain in rats. Wala EP, Holtman JR, Sloan PA. J Opioid Manag; 2013 Mar 03; 9(2):85-96. PubMed ID: 23709318 [Abstract] [Full Text] [Related]
18. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats. Christensen D, Guilbaud G, Kayser V. Anesthesiology; 2000 Mar 03; 92(3):786-94. PubMed ID: 10719957 [Abstract] [Full Text] [Related]
19. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats. Wang JY, Zhao M, Yuan YK, Fan GX, Jia H, Tang JS. Neuroscience; 2006 Mar 03; 138(4):1319-27. PubMed ID: 16472929 [Abstract] [Full Text] [Related]
20. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors. Catheline G, Kayser V, Guilbaud G. Eur J Pharmacol; 1996 Nov 14; 315(2):135-43. PubMed ID: 8960876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]